Tempur-Pedic International Rises On Unusually High Volume (TPX)

NEW YORK ( TheStreet) -- Tempur-Pedic International (NYSE: TPX) is trading at unusually high volume Friday with 14.5 million shares changing hands. It is currently at four times its average daily volume and trading up $3.06 (+13.7%) at $25.45 as of 3:15 p.m. ET.

Tempur-Pedic International has a market cap of $1.42 billion and is part of the consumer goods sector and consumer durables industry. Shares are down 16.9% year to date as of the close of trading on Thursday.

Tempur-Pedic International Inc. engages in the manufacture, marketing, and distribution of bedding products in North America and internationally. It offers mattresses, pillows, and adjustable bed bases, as well as various cushions and other comfort products. The company has a P/E ratio of 6.7, equal to the average consumer durables industry P/E ratio and below the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates Tempur-Pedic International as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, notable return on equity, expanding profit margins, impressive record of earnings per share growth and compelling growth in net income. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself. You can view the full Tempur-Pedic International Ratings Report.

See all heavy volume stocks in our stocks moving on unusual volume list or get investment ideas from our investment research center.
null

If you liked this article you might like

Stocks Mostly Lower in Cautious Trading, Apple Slips on Downgrade

Stocks Mostly Lower in Cautious Trading, Apple Slips on Downgrade

Stocks Under Pressure After London Terror Attacks, Apple Downgrade

Stocks Under Pressure After London Terror Attacks, Apple Downgrade

Stocks to Retreat From Records at the Open After London Terror Attacks

Stocks to Retreat From Records at the Open After London Terror Attacks

Insiders Are Loading Up on Kite Pharma, Cliffs Natural Resources and More

Insiders Are Loading Up on Kite Pharma, Cliffs Natural Resources and More